V

Veracyte
D

VCYT

27.200
USD
-0.40
(-1.45%)
مغلق
حجم التداول
15,012
الربح لكل سهم
1
العائد الربحي
-
P/E
66
حجم السوق
2,130,157,419
أصول ذات صلة
A
ADPT
0.350
(3.05%)
11.820 USD
BMRN
BMRN
0.560
(0.98%)
57.750 USD
DXCM
DXCM
-0.640
(-0.77%)
82.920 USD
F
FATE
0.02000
(1.80%)
1.13000 USD
REGN
REGN
-0.69
(-0.13%)
546.88 USD
R
RGEN
0.490
(0.39%)
127.440 USD
T
TDOC
-0.05500
(-0.66%)
8.29500 USD
VEEV
VEEV
1.65
(0.58%)
284.30 USD
المزيد
الأخبار المقالات

العنوان: Veracyte

القطاع: Healthcare
الصناعة: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.